BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30654370)

  • 1. Can Iodixanol Prevent Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis? A Prospective, Randomized, Controlled Trial.
    Ogura T; Imoto A; Okuda A; Fukunishi S; Higuchi K
    Dig Dis; 2019; 37(3):255-261. PubMed ID: 30654370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
    Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
    World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of ionic, monomer, high osmolar contrast media with non-ionic, dimer, iso-osmolar contrast media in ERCP.
    Ogawa M; Kawaguchi Y; Kawashima Y; Mizukami H; Maruno A; Ito H; Mine T
    Tokai J Exp Clin Med; 2013 Sep; 38(3):109-13. PubMed ID: 24030487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic stents for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis should be inserted up to the pancreatic body or tail.
    Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Takasumi M; Hikichi T; Ohira H
    World J Gastroenterol; 2018 Jun; 24(22):2392-2399. PubMed ID: 29904246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of two types of contrast media used in endoscopic retrograde cholangiopancreatography: A retrospective study.
    Matsuura T; Hamaya Y; Onoue S; Tamura S; Ishida N; Yamade M; Tani S; Iwaizumi M; Osawa S; Furuta T; Sugimoto K
    PLoS One; 2023; 18(1):e0280279. PubMed ID: 36608042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of somatostatin on prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis and hyperamylasemia: A systematic review and meta-analysis.
    Wang G; Xiao G; Xu L; Qiu P; Li T; Wang X; Wen P; Wen J; Xiao X
    Pancreatology; 2018 Jun; 18(4):370-378. PubMed ID: 29550097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is prophylactic somatostatin effective to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis or hyperamylasemia? A randomized, placebo-controlled pilot trial.
    Wang ZK; Yang YS; Cai FC; Wang YH; Shi XL; Ding C; Li W
    Chin Med J (Engl); 2013 Jul; 126(13):2403-8. PubMed ID: 23823808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for post-ERCP pancreatitis and hyperamylasemia: A retrospective single-center study.
    He QB; Xu T; Wang J; Li YH; Wang L; Zou XP
    J Dig Dis; 2015 Aug; 16(8):471-8. PubMed ID: 25955444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of Raw Rhubarb Solution in the Precaution of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis in Patients with High-Risk Factors: A Predictive Random Compared Research in One Center.
    Wang C; Li Q; Ye P; Zeng S; Li GH; Chen YX; Zhou XJ; Lv NH
    Dig Dis Sci; 2017 Apr; 62(4):1043-1050. PubMed ID: 28194668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celecoxib Oral Administration for Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Randomized Prospective Trial.
    Kato K; Shiba M; Kakiya Y; Maruyama H; Ominami M; Fukunaga S; Sugimori S; Nagami Y; Watanabe T; Tominaga K; Fujiwara Y
    Pancreas; 2017 Aug; 46(7):880-886. PubMed ID: 28697127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic somatostatin can reduce incidence of post-ERCP pancreatitis: multicenter randomized controlled trial.
    Bai Y; Ren X; Zhang XF; Lv NH; Guo XG; Wan XJ; Nie ZG; Han ST; Bie P; Tian DA; Ji M; Li ZS
    Endoscopy; 2015 May; 47(5):415-20. PubMed ID: 25590178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indomethacin down-regulating HMGB1 and TNF-α to prevent pancreatitis after endoscopic retrograde cholangiopancreatography.
    Li L; Liu M; Zhang T; Jia Y; Zhang Y; Yuan H; Zhang G; He C
    Scand J Gastroenterol; 2019 Jun; 54(6):793-799. PubMed ID: 31177924
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial.
    Li ZS; Pan X; Zhang WJ; Gong B; Zhi FC; Guo XG; Li PM; Fan ZN; Sun WS; Shen YZ; Ma SR; Xie WF; Chen MH; Li YQ
    Am J Gastroenterol; 2007 Jan; 102(1):46-51. PubMed ID: 17266687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial.
    Lee KT; Lee DH; Yoo BM
    Pancreas; 2008 Nov; 37(4):445-8. PubMed ID: 18953260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic temporary 3F pancreatic duct stent to prevent post-ERCP pancreatitis in patients with a difficult biliary cannulation: a multicenter, prospective, randomized study.
    Lee TH; Moon JH; Choi HJ; Han SH; Cheon YK; Cho YD; Park SH; Kim SJ
    Gastrointest Endosc; 2012 Sep; 76(3):578-85. PubMed ID: 22771100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of immunosuppression in post-endoscopic retrograde cholangiopancreatography pancreatitis after liver transplantation: a retrospective analysis.
    Law R; Leal C; Dayyeh BA; Leise MD; Balderramo D; Baron TH; Cardenas A
    Liver Transpl; 2013 Dec; 19(12):1354-60. PubMed ID: 24115362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the Use of Low Osmolality Contrast Medium Reduce the Frequency of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Comparative Study between Use of Low and High Osmolality Contrast Media.
    Nagashima K; Ijima M; Kimura K; Kurihara E; Tominaga K; Fukushi K; Kanamori A; Otake Y; Irisawa A
    Digestion; 2021; 102(2):283-288. PubMed ID: 31770751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nafamostat Mesylate is Not Effective in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.
    Matsumoto T; Okuwaki K; Imaizumi H; Kida M; Iwai T; Yamauchi H; Kaneko T; Hasegawa R; Masutani H; Tadehara M; Adachi K; Watanabe M; Kurosu T; Tamaki A; Kikuchi H; Ohno T; Koizumi W
    Dig Dis Sci; 2021 Dec; 66(12):4475-4484. PubMed ID: 33495919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of prophylactic allopurinol use in post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Zheng M; Chen Y; Bai J; Xin Y; Pan X; Zhao L
    Pancreas; 2008 Oct; 37(3):247-53. PubMed ID: 18815544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. History of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis and Acute Pancreatitis as Risk Factors for Post-ERCP Pancreatitis.
    Funatsu E; Masuda A; Takenaka M; Nakagawa T; Shiomi H; Yoshinaka H; Kobayashi T; Sakai A; Yagi Y; Yoshida M; Arisaka Y; Okabe Y; Kutsumi H; Azuma T
    Kobe J Med Sci; 2017 May; 63(1):E1-E8. PubMed ID: 29434167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.